DrugPatentWatch Database Preview
Details for Patent: 8,415,335
Email this page to a colleague
See Plans and PricingWhich drugs does patent 8,415,335 protect, and when does it expire?
Patent 8,415,335 protects VASCEPA and is included in one NDA.
This patent has thirty-two patent family members in twenty-one countries.
Summary for Patent: 8,415,335
| Title: | Methods of treating hypertriglyceridemia |
| Abstract: | In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof. |
| Inventor(s): | Manku; Mehar (England, GB), Osterloh; Ian (Kent, GB), Wicker; Pierre (Mystic, CT), Braeckman; Rene (Richboro, PA), Soni; Paresh (Mystic, CT) |
| Assignee: | Amarin Pharmaceutical Ireland Limited (Dublin, IE) |
| Application Number: | 13/349,157 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,415,335 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; |
Drugs Protected by US Patent 8,415,335
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-001 | Jul 26, 2012 | RX | Yes | Yes | Start Trial | Start Trial | METHOD OF REDUCING TG LEVELS IN PATIENT SUFFERING FROM SEVERE HYPERTRIGLYCERIDEMIA | Start Trial | ||||
| Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-002 | Feb 16, 2017 | RX | Yes | No | Start Trial | Start Trial | METHOD OF REDUCING TG LEVELS IN PATIENT SUFFERING FROM SEVERE HYPERTRIGLYCERIDEMIA | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,415,335
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2010213899 | Start Trial | |||
| Brazil | PI1007518 | Start Trial | |||
| Canada | 2751576 | Start Trial | |||
| Canada | 3008079 | Start Trial | |||
| Cyprus | 1114276 | Start Trial | |||
| Denmark | 2395991 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
